Improvements in Digestive Symptoms After Participation in an App-Based Chronic Digestive Disease Management Program: A Prospective Cohort Evaluation

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2024 Sep 16

PMID 39280538

Authors

Dena M Bravata

Hau Liu

Meghan M Colosimo

Alexander C Bullock

Erin Commons

Mark Pimentel

Affiliations

Soon will be listed here.

Abstract

Background: Fewer than 20% of adults with chronic gastrointestinal (GI) symptoms have accessed care to evaluate or manage their symptoms. We sought to characterize whether adults with chronic GI symptoms would use an app for symptom monitoring and the effects of participation in a digitally delivered GI chronic care program.

Methods: We provided a digital digestive care management app to adults via their employer-sponsored benefits. We evaluated participants' self-reported GI symptoms at baseline and between 30 and 90 days post-registration. GI symptoms (e.g., abdominal pain and constipation) were rated on a scale of 0 (no symptoms) to 4 (very severe symptoms).

Results: A total of 1936 participants were enrolled (75% female; 67% White, 11% Asian/Pacific Islander, 6% Hispanic, 7% Black; mean age: 43 years). Their most common GI conditions were irritable bowel syndrome (IBS), gastroesophageal reflux disease (GERD), and acid reflux. Participants of all genders and races reported statistically significant improvements in all symptoms between baseline and the end of the intervention (P < 0.05). At baseline, 79.5% of participants reported at least moderate GI symptom severity for at least one symptom. In contrast, at the end of the intervention, only 47.8% of participants reported moderate or severe symptoms, and 310 (16.0%) participants reported no symptoms. Participants who were scheduled with their care team reported greater symptom improvement than those who were not scheduled (P = 0.004). Participants reported feeling greater control of their health (83%), better management of their digestive symptoms (83%), increased happiness (76%), and greater productivity at work (54%).

Conclusion: Demographically diverse participants engaged with a digital digestive chronic care program and reported significant improvements in digestive symptom severity.

References

Sasegbon A, Vasant D . Understanding racial disparities in the care of patients with irritable bowel syndrome: The need for a unified approach. Neurogastroenterol Motil. 2021; 33(5):e14152. DOI: 10.1111/nmo.14152. View

Kim Y, Kim N . Sex-Gender Differences in Irritable Bowel Syndrome. J Neurogastroenterol Motil. 2018; 24(4):544-558. PMC: 6175559. DOI: 10.5056/jnm18082. View

Koloski N, Jones M, Hammer J, von Wulffen M, Shah A, Hoelz H . The Validity of a New Structured Assessment of Gastrointestinal Symptoms Scale (SAGIS) for Evaluating Symptoms in the Clinical Setting. Dig Dis Sci. 2017; 62(8):1913-1922. DOI: 10.1007/s10620-017-4599-6. View

Singh M, James S, Germino G, Rodgers G . Achieving Health Equity Through Digestive Diseases Research and Scientific Workforce Diversity. Gastroenterology. 2022; 162(6):1597-1601.e1. PMC: 9038710. DOI: 10.1053/j.gastro.2022.01.005. View

Tarro L, Llaurado E, Ulldemolins G, Hermoso P, Sola R . Effectiveness of Workplace Interventions for Improving Absenteeism, Productivity, and Work Ability of Employees: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Int J Environ Res Public Health. 2020; 17(6). PMC: 7142489. DOI: 10.3390/ijerph17061901. View

Peery A, Crockett S, Murphy C, Lund J, Dellon E, Williams J . Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2018. Gastroenterology. 2018; 156(1):254-272.e11. PMC: 6689327. DOI: 10.1053/j.gastro.2018.08.063. View

Wang A, Mattek N, Holub J, Lieberman D, Eisen G . Prevalence of complicated gastroesophageal reflux disease and Barrett's esophagus among racial groups in a multi-center consortium. Dig Dis Sci. 2009; 54(5):964-71. PMC: 3856566. DOI: 10.1007/s10620-009-0742-3. View

Fitzpatrick J, Melton S, Yao C, Gibson P, Halmos E . Dietary management of adults with IBD - the emerging role of dietary therapy. Nat Rev Gastroenterol Hepatol. 2022; 19(10):652-669. DOI: 10.1038/s41575-022-00619-5. View

Crowell M, Umar S, Lacy B, Jones M, DiBaise J, Talley N . Multi-Dimensional Gastrointestinal Symptom Severity Index: Validation of a Brief GI Symptom Assessment Tool. Dig Dis Sci. 2015; 60(8):2270-9. DOI: 10.1007/s10620-015-3647-3. View

10.

Reznikov E, Suskind D . Current Nutritional Therapies in Inflammatory Bowel Disease: Improving Clinical Remission Rates and Sustainability of Long-Term Dietary Therapies. Nutrients. 2023; 15(3). PMC: 9920576. DOI: 10.3390/nu15030668. View

11.

Svedlund J, Sjodin I, DOTEVALL G . GSRS--a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci. 1988; 33(2):129-34. DOI: 10.1007/BF01535722. View

12.

Spiegel B, Hays R, Bolus R, Melmed G, Chang L, Whitman C . Development of the NIH Patient-Reported Outcomes Measurement Information System (PROMIS) gastrointestinal symptom scales. Am J Gastroenterol. 2014; 109(11):1804-14. PMC: 4285435. DOI: 10.1038/ajg.2014.237. View

13.

Sandler R, Stewart W, Liberman J, Ricci J, Zorich N . Abdominal pain, bloating, and diarrhea in the United States: prevalence and impact. Dig Dis Sci. 2000; 45(6):1166-71. DOI: 10.1023/a:1005554103531. View

14.

Mathews S, Izmailyan S, Brito F, Yamal J, Mikhail O, Revere F . Prevalence and Financial Burden of Digestive Diseases in a Commercially Insured Population. Clin Gastroenterol Hepatol. 2021; 20(7):1480-1487.e7. DOI: 10.1016/j.cgh.2021.06.047. View

15.

Ahuja A, Pelton M, Raval S, Kesavarapu K . Role of Nutrition in Gastroesophageal Reflux, Irritable Bowel Syndrome, Celiac Disease, and Inflammatory Bowel Disease. Gastro Hep Adv. 2024; 2(6):860-872. PMC: 11307716. DOI: 10.1016/j.gastha.2023.06.010. View

16.

Kaplan R, Hays R . Health-Related Quality of Life Measurement in Public Health. Annu Rev Public Health. 2021; 43:355-373. DOI: 10.1146/annurev-publhealth-052120-012811. View

17.

Neri L, Basilisco G, Corazziari E, Stanghellini V, Bassotti G, Bellini M . Constipation severity is associated with productivity losses and healthcare utilization in patients with chronic constipation. United European Gastroenterol J. 2014; 2(2):138-47. PMC: 4040810. DOI: 10.1177/2050640614528175. View

18.

Everhart J, Ruhl C . Burden of digestive diseases in the United States part I: overall and upper gastrointestinal diseases. Gastroenterology. 2009; 136(2):376-86. DOI: 10.1053/j.gastro.2008.12.015. View

19.

Singh R, Salem A, Nanavati J, Mullin G . The Role of Diet in the Treatment of Irritable Bowel Syndrome: A Systematic Review. Gastroenterol Clin North Am. 2018; 47(1):107-137. DOI: 10.1016/j.gtc.2017.10.003. View

20.

Khanna D, Hays R, Shreiner A, Melmed G, Chang L, Khanna P . Responsiveness to Change and Minimally Important Differences of the Patient-Reported Outcomes Measurement Information System Gastrointestinal Symptoms Scales. Dig Dis Sci. 2017; 62(5):1186-1192. PMC: 5532518. DOI: 10.1007/s10620-017-4499-9. View